30
Nov 2021
Latest News
Arise Biotech was Shortlisted for 2021 SBIR Grant
Arise Biotech Corporation, as a provider of innovative and high-quality equipment of life science, a developer and a manufacturer of reagents and consumables, was shortlisted for the 2021 SBIR Grant. It aims to complete the development of the first LED QPCR in Taiwan in Q1 2022 to promote highly efficient universal PCR for disease detection at a low cost. Backed and executed by the Ministry of Economic Affairs, the SBIR program aims to encourage SMEs to invest in the innovation and R&D of products and technologies to improve the competitiveness of Taiwan’s industry at the international market.
With close to two decades of experience in international R&D, Arise Biotech invests 25% of its revenue in innovation and R&D every year. The first generation qPCR equipment fitted with a halogen lamp is developed under the collaboration between Arise Biotech and Industrial Technology Research Institute (ITRI). The development of the qPCR prototype launched this time can help our internal team apply their expertise in optical module set. With innovative design of single-well scanning backed by LED light, it size of the instrument is estimated to decrease by 30%. The scanning model allows one scanning under 5 second. Compared to the first generation, the cost of massive production of this model could be reduced by over 60% so that the testing capacity of the Taiwan qPCR can be improved and dependence on import of foreign models throughout Taiwan can be avoided.
James Lo, General Manager of Arise Biotech stated that: “We are the first developer of qPCR instrument in Taiwan, and we use florescent signals at multiple wavelengths to detect the quantity of viral nucleic acid. Apart from ensuring the precision of optical design, another essential factor is to reduce the systematic cost of equipment to popularize the application. The new generation qPCR equipment backed by LED light adopts smaller filer, LED light source and photodiode sensor to reduce the size, making it more convenient for the highly efficient screening of virus.”
The new generation qPCR equipment backed by LED light is equipped with 16 wells and fluorescent probes of four colors for scanning. In the future, the company plans to develop a design with 96 wells to continue lowering the cost for rapid scanning and producing small optical system to popularize qPCR.
With close to two decades of experience in international R&D, Arise Biotech invests 25% of its revenue in innovation and R&D every year. The first generation qPCR equipment fitted with a halogen lamp is developed under the collaboration between Arise Biotech and Industrial Technology Research Institute (ITRI). The development of the qPCR prototype launched this time can help our internal team apply their expertise in optical module set. With innovative design of single-well scanning backed by LED light, it size of the instrument is estimated to decrease by 30%. The scanning model allows one scanning under 5 second. Compared to the first generation, the cost of massive production of this model could be reduced by over 60% so that the testing capacity of the Taiwan qPCR can be improved and dependence on import of foreign models throughout Taiwan can be avoided.
James Lo, General Manager of Arise Biotech stated that: “We are the first developer of qPCR instrument in Taiwan, and we use florescent signals at multiple wavelengths to detect the quantity of viral nucleic acid. Apart from ensuring the precision of optical design, another essential factor is to reduce the systematic cost of equipment to popularize the application. The new generation qPCR equipment backed by LED light adopts smaller filer, LED light source and photodiode sensor to reduce the size, making it more convenient for the highly efficient screening of virus.”
The new generation qPCR equipment backed by LED light is equipped with 16 wells and fluorescent probes of four colors for scanning. In the future, the company plans to develop a design with 96 wells to continue lowering the cost for rapid scanning and producing small optical system to popularize qPCR.
